Upload
nika
View
54
Download
1
Tags:
Embed Size (px)
DESCRIPTION
INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland. Józef Woźny- President. Pharmaceutical Sector in Poland. - PowerPoint PPT Presentation
Citation preview
INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND
T.U. Federation of Chemical, Glass and Ceramic Industries in Poland.
Józef Woźny- President
National Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses.
It also has a great importance for the economy of providing 55% of the medicines sold in Poland.
Polish pharmaceutical industry is one of the largest generic medicines producer in Europe.
It provides public access to medicines of good quality with benefit price (more than 50% of the packages in the market comes from domestic plants).
Pharmaceutical Sector in Poland
Average prices of generic and innovative medicines in Europe(net producer prices, EUR)
Niemcy
Finlan
diaBelg
ia
Luks
embu
rg
Norweg
ia
Austri
a
Portu
galia
Grecja
Hiszpa
nia
Fran
cja
Słowac
ja
Włochy
Wlk. B
rytan
ia
Węgry
Esto
niaŁo
twa
Litwa
Rumun
ia
Polska
Bułgar
ia0
2
4
6
8
10
12
14
16
18 17.1
14.613.312.912.6
10.09.2 9.0
8.37.1 6.6 6.5 6.4 5.9 5.9
4.7 4.5 4.2 3.6 3.0
Structure of the Polish pharmaceutical market broken down by original and generic medicines in 2011 (net producer prices).
Quantitative Valuable
Oryginal Generic
Only one plant-Polfa Tarchomin remains in the hands of the Treasury.
Pharmaceutical Sector in Poland:
Privatization process:
Polfa Poznań GlaxoSmithKlinePolfa Rzeszów Valeant (formerly ICN)Polfa Kraków Pliva /TevaPolfa Grodzisk Gedeon RichterPolfa Kutno TevaFabryka w Starogardzie Gdańskim
National invetor- Jerzy Starak
Polfa Pabianice National company-Adamed
Domestic pharmaceutical companies more than 60% of the profit is investing. These investments have allowed companies such as for:
Process to complete implementation of Quality Management Systems, implementation of Good Manufacturing Practice (GMP),
the adjustment of medicines documents with European Union requirements,
employment restructuring, development cooperation programs in science, increase in the number of patents, the development of biotechnology, the adaptation of production to high standards of environmental protection. Domestic pharmaceutical companies spend on research and development, 13% of the profits, where the average for the processing industry in Poland is 3.5%.
Pharmaceutical Sector in Poland
The export of medicines to EU countries are 75.6%. Among the countries to which exported the Polish medicine complex, the majority were:
Germany (15.5% of Polish exports) and the United Kingdom,
France and Russia (about 9% of Polish foreign sales).
Pharmaceutical Sector in Poland
Domestic pharmaceutical industry employs approx. 23 000 peoples.
Amount of workers in pharmaceutical industry in the years 2006-2010 (in the person of the end of the year)
Salary in the manufacturing industry was 3 250.00 PLN in the pharmaceutical industry 5 319.00 PLN.
The average monthly salary per employee in manufacturing and pharmaceutical industry
in the years 2006-2010.
Trade Union membership in the pharmaceutical industry is in the range of 30-35%.
In the factories functioning Works Collective Labour Agreements.
Where are the European Works Council representatives of Polish pharmaceutical companies are authorized.
Works Council functioning of each plant.
Multi-establishment collective agreement is not signed, has not given its consent Employers Association of Pharmaceutical Industries.
Pharmaceutical Sector in Poland
Activities in the area of corporate social responsibility
Charitable activities
Sponsoring of sport and cultural news
Organized of seminars and science conferences
Information actions for the patients
Investments in environmental
Free diagnostics for patients
Other
Companies don’t take activities on this field.
Impacts that could affect most business development in Polish pharmaceutical sector.
The introduction a new products in market
The overall increase in wealth of the society
The access to reimbursement
The access to investment funds
Improving the law system
The marketing actions
Improving quality of products
Output from outside the polish market
Increasing health consciousness of Poles
Increasing of amount of sales representatives
THANK YOU FOR ATTENTION !
Presentation prepared on the basis of the documentation:1. Polish Employers Association in the Pharmaceutical Industry 2. Department of Economic Information- Invest In Poland3. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland
Pharmaceutical Sector in Poland